What is the cognitive assessment in the Medicare Annual Wellness Visit?

It is a brief detection screen performed by the primary care provider during the Annual Wellness Visit. CMS does not mandate a specific tool, but the most common are the Mini-Cog (a three-item recall and clock draw), the GPCOG (a brief informant and patient version), and the Memory Impairment Screen. The screen takes a few minutes. If it is normal, the AWV concludes with the standard prevention plan. If it is abnormal, the provider plans a follow-up cognitive evaluation, often the CPT 99483 visit.

Is the cognitive screen free?

Yes. The Annual Wellness Visit, including the cognitive screen, is covered at no cost to the patient. No deductible, no coinsurance. The visit must be billed as an AWV (not as a regular office visit) for the no-cost rule to apply. If the patient also raises new symptoms or chronic disease management during the visit, the provider may bill an additional E/M code with normal cost-sharing.

CPT 99483 is the cognitive care planning visit. It is a 50-minute, in-person visit that includes a structured cognitive assessment, functional assessment, medication review, safety evaluation, caregiver assessment, and the creation of a written care plan. It is the formal Medicare pathway for working up a positive screen. Part B pays 80 percent after the deductible. Patient or Medigap pays the remaining 20 percent. Medi-Cal covers the coinsurance for dual-eligibles.

What is the difference between MMSE, MoCA, and Mini-Cog?

The Mini-Cog is the briefest (three-item recall and clock draw, two to three minutes), suitable for primary care screening but less precise for mild impairment. The MMSE (Mini-Mental State Examination) is a 30-point exam covering orientation, registration, attention, recall, language, and visuospatial skills; 10 to 15 minutes. The MoCA (Montreal Cognitive Assessment) is similar in length but more sensitive to mild cognitive impairment and the executive dysfunction seen in vascular and frontotemporal dementia. Most California specialists use the MoCA for diagnostic workups.

What happens if the screen is positive?

A positive screen is not a diagnosis. It is a signal for a deeper workup. The standard path: a cognitive care planning visit (CPT 99483) with the primary care provider, often a referral to a geriatrician or neurologist, basic labs to rule out reversible causes (B12 deficiency, thyroid disease, depression, medication side effects), brain imaging when indicated, and sometimes a referral to a memory clinic or California Alzheimer's Disease Center for complex cases.

Why does early detection matter?

Several reasons. Advance care planning is much easier when the patient still has capacity. Lifestyle interventions (exercise, sleep, blood pressure control, hearing aids, social engagement) have their largest effect in the mild stage. Clinical trial eligibility, including for new disease-modifying therapies, is largely limited to early-stage patients. The federal GUIDE Model dementia care coordination program enrolls earlier-stage patients. And families plan better when they have more runway.

What is the GUIDE Model and how does it connect to cognitive assessment?

GUIDE (Guiding an Improved Dementia Experience) is a CMS Innovation Center model launched in 2024 and 2025 that pays primary care and specialty practices a monthly fee to coordinate dementia care. Enrollment requires a documented dementia diagnosis. A positive cognitive screen followed by a confirmed diagnosis is the typical pathway into a GUIDE-participating practice. Several California academic centers and a smaller number of community practices participate.

Cognitive assessment under Medicare: AWV and CPT 99483

What the Medicare Annual Wellness Visit actually is

The Annual Wellness Visit (AWV) is an annual preventive visit, covered at no cost to the patient, available to any Medicare beneficiary who has been enrolled in Part B for at least 12 months. It is not a physical exam in the traditional sense; it is a structured review of health risks, functional status, cognition, and prevention planning. The first AWV (called the “Initial AWV”) is longer and more detailed. Subsequent AWVs are streamlined.

Among other things, the AWV includes a depression screen, a cognitive impairment screen, a functional status review, a review of risk factors and chronic conditions, an updated medication list, an advance care planning discussion if the patient consents, and a personalized prevention plan. The cognitive screen is one of the most useful components, and the one most often skipped in a hurried primary care visit.

How the cognitive screen works

CMS does not require a specific tool, but it does require the provider to use a validated screen and document the result. The most common choices in California primary care:

Mini-Cog (two to three minutes): a three-item recall plus clock draw. Quick, simple, reasonably sensitive for moderate impairment, less sensitive for mild.
GPCOG (General Practitioner Assessment of Cognition): a brief patient test plus an optional informant interview. Designed for primary care.
Memory Impairment Screen: a four-item delayed recall, with cuing.

The MMSE and MoCA are typically reserved for diagnostic workups, not primary care screening, because they take 10 to 15 minutes each and are more sensitive than the screen needs to be. A primary care office that routinely uses the MoCA for screening is usually a primary care office with strong dementia interest, often participating in the Dementia Care Aware training in California.

The distinction between detection and diagnosis

A cognitive screen detects the possibility of impairment. It does not diagnose. A positive Mini-Cog or GPCOG result tells the provider to look further; it does not tell the family that their parent has Alzheimer’s disease.

The diagnostic workup is separate and longer. It includes a detailed cognitive examination (MMSE, MoCA, or neuropsychological testing in complex cases), a thorough history, an informant interview with a family member, basic labs (B12, TSH, basic metabolic panel), brain imaging when indicated (MRI is preferred over CT), and sometimes specialty referral to a geriatrician, neurologist, or memory clinic. California Alzheimer’s Disease Centers at the UC academic medical centers handle the most complex cases.

CPT 99483 and the cognitive care planning visit

When a screen is positive, or when a patient presents with documented cognitive concerns, the provider can bill CPT 99483, the cognitive assessment and care plan service. The visit is 50 minutes and includes:

A structured cognitive examination (MoCA or equivalent)
A functional assessment (ADLs and IADLs)
A safety evaluation (driving, home safety, wandering risk, firearms, finances)
A medication review focused on drugs that worsen cognition
A neuropsychiatric symptom inventory
A caregiver assessment
A written care plan delivered to the patient and family

CPT 99483 was created to give primary care providers a reimbursement pathway for the time it actually takes to work up cognitive impairment properly. Before this code, the work was being done unpaid or not done at all. Adoption has grown since 2020 but is still uneven; not every California primary care practice uses it.

Why early detection matters

Four practical reasons.

Advance care planning. Decisions about durable power of attorney, financial management, end-of-life preferences, and long-term care insurance are far easier to make when the patient has capacity. The window closes faster than families expect.

Lifestyle interventions. Blood pressure control, exercise, sleep treatment, hearing aid use, smoking cessation, and social engagement have their largest impact in the mild stage. The Lancet Commission on dementia prevention identifies these and several other modifiable risk factors.

Clinical trial eligibility.New disease-modifying therapies for Alzheimer’s disease (lecanemab, donanemab) are limited to early-stage patients. So are most ongoing clinical trials. A patient with a year-old diagnosis often has options that a patient with a five-year-old diagnosis no longer has.

GUIDE Model enrollment. The CMS GUIDE Model dementia care coordination program requires a documented dementia diagnosis. Patients identified through a positive cognitive screen and confirmed in a CPT 99483 visit can enroll in a participating practice and access a dementia care navigator, 24/7 clinical access, caregiver education, and respite, all at no cost.

What happens after a positive screen

The provider explains the screen result and the next steps to the patient and a family member. Most California families benefit from having a family member present for this conversation.
The provider schedules a CPT 99483 cognitive care planning visit, often two to four weeks later to allow for labs and imaging.
Basic labs (TSH, B12, comprehensive metabolic panel) and, if indicated, brain MRI are ordered.
The provider reviews the patient’s medication list for drugs that worsen cognition: anticholinergics (diphenhydramine, oxybutynin), benzodiazepines, sedating antihistamines, certain antidepressants.
The CPT 99483 visit consolidates the workup and produces a written care plan that the family can use to guide the next 12 months.
Referral to a geriatrician, neurologist, or California Alzheimer’s Disease Center is made if the diagnosis is unclear, if the patient is younger than 65, or if the family wants a second opinion before accepting a diagnosis.

Why so few California seniors get screened

Several reasons converge. AWV adoption is uneven; many California Medicare beneficiaries do not have an AWV scheduled separately from their regular office visits. Primary care providers are busy and the cognitive screen is easy to omit. Patients and families often resist, worried about what a positive result will mean. And the workup pathway after a positive screen is uneven; not every primary care practice is comfortable performing the CPT 99483 visit or making the right referral.

The result: roughly 20 to 25 percent of California seniors with dementia are never formally diagnosed. They lose years of planning time, treatment opportunity, and family preparation. Pushing for the AWV cognitive screen is one of the most valuable things a family can do.

Common misconceptions to clear up

“A cognitive screen is the same as a diagnosis.” It isn’t. The screen detects the possibility of impairment. Diagnosis is a separate, longer process.

“If we don’t look, there’s nothing to find.” Cognitive impairment progresses whether or not it is documented. Detection enables planning and treatment.

“The Annual Wellness Visit is just a regular checkup.” It is a structured Medicare benefit with specific covered elements, including the cognitive screen and the depression screen, billed differently from a standard office visit and paid at zero cost-sharing.

“If the screen is positive, there is nothing to do.” There is a great deal to do: advance care planning, lifestyle interventions, medication review, clinical trial consideration, GUIDE Model enrollment, and family preparation. The earlier the better.

Related services and next steps

This guide explains coverage and eligibility, not medical advice. Talk to a licensed clinician about care decisions. California Care Compass does not place referrals on Services & Treatments pages.

Cognitive assessment under Medicare: the visit most families skip, and why they shouldn't.